Vanberra Signal

Acumenta

Curated by Signal

Acumenta offers data mining solutions for biotech and life sciences.

Overview

Acumenta offers data mining solutions for biotech and life sciences. Products include Literature Lab, a data mining solution that claims to aid researchers to explore domain concurrences in publications using Log of Product Frequency (LPF), LPF measures relative intensities of associations without volume bias, identify concomitant diseases and genes involved, and identify pathways and diseases associated with chemicals, drugs, and substances; and Literature Lab PLUS that builds on top of the LPF using statistical and clustering analysis to illuminate functional relationships in gene or protein sets and can be used to explore Gene x Domain Concurrences in publications using Log of Product Frequency, identify disease driver genes, and explore gene contributions for pathways, diseases, and pharmacologic actions.

Key facts

Founded
1990

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of fall detection and prevention device for patients

    Health TechnologyLincoln, United States
  • Provider of a SaaS-based medical device quality management software for healthcare professionals

    Health TechnologyMorrisville, United States
  • Cloud-based practice management tool for healthcare professionals

    Health TechnologyExcelsior, United States

About Acumenta

What does Acumenta do?

Acumenta offers data mining solutions for biotech and life sciences.

Where is Acumenta headquartered?

Acumenta is headquartered in Boston, United States.

When was Acumenta founded?

Acumenta was founded in 1990.

Which sector is Acumenta in?

Acumenta operates in Health Technology.

Who are Acumenta's competitors?

Companies similar to Acumenta include Ocuvera, LuminLogic, and CLG Health.